Check out the companies making headlines before the bell:

Eli Lilly – The drugmaker reported adjusted quarterly profit of $1.33 per share, falling a penny a share below estimates. Revenue beat forecasts as its newer drugs posted higher sales. Lilly also cut its full-year forecast relating to its pending acquisition of Loxo Oncology.